(Q40042183)

16 September 2017

Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius (English)

1 reference

16 September 2017

0 references

0 references

1 reference

Adrian J Cameron

1

0 references

Stefan Söderberg

object named as

Stefan Söderberg

5

0 references

Edward J. Boyko

object named as

Edward J Boyko

2

0 references

Jaakko Tuomilehto

7

object named as

Jaakko Tuomilehto

1 reference

16 September 2017

4

Paul Z Zimmet

1 reference

16 September 2017

8

Pierrot Chitson

1 reference

16 September 2017

Richard A Sicree

3

1 reference

PubMed ID

18820650

16 September 2017

K George M M Alberti

6

1 reference

PubMed ID

18820650

16 September 2017

Jonathan E Shaw

9

1 reference

16 September 2017

25 September 2008

1 reference

16 September 2017

1 reference

16 September 2017

16

1 reference

16 September 2017

12

1 reference

16 September 2017

2707-2716

1 reference

Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X.

16 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Development of the multiple metabolic syndrome in the ARIC cohort: joint contribution of insulin, BMI, and WHR. Atherosclerosis risk in communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Changes in features of the metabolic syndrome and incident impaired glucose regulation or type 2 diabetes in a chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the D.E.S.I.R. cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)--methods and response rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Increasing prevalence of Type 2 diabetes mellitus in all ethnic groups in Mauritius

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Statistics notes: Analysing controlled trials with baseline and follow up measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Insulin resistance and hypertension: the chicken-egg question revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Adipose tissue arachidonic acid and the metabolic syndrome in Costa Rican adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Obesity, Inflammation, and Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Adiponectin and Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Leptin, but not adiponectin, predicts stroke in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

PAI-1 and the metabolic syndrome: links, causes, and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Temporal association between obesity and hyperinsulinemia in children, adolescents, and young adults: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Comparison of 11 human insulin assays: implications for clinical investigation and research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Association between different measurements of obesity and the incidence of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Mauritius Non-communicable Disease Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Statistical methods for describing temporal order in longitudinal research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.412

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2008.412

1 reference

16 September 2017

1 reference

PubMed ID

18820650